Skip to main content
. 2021 Jul 18;10(9):1071–1080. doi: 10.1002/psp4.12675

TABLE 3.

Model‐predicted geometric mean steady‐state Cmax and AUC values for olanzapine and samidorphan after once‐daily doses of OLZ/SAM 10 mg/10 mg for 14 days in subjects with hepatic impairment compared with age‐matched healthy controls (model application)

Variable Cmax,ss, ng/ml AUCss, ng h/ml
Healthy control

Mild

HI

Moderate HI

Severe

HI

Healthy control

Mild

HI

Moderate

HI

Severe

HI

Olanzapine 34.4 40.9 51.2 53.2 688 783 1031 1077
Ratioa 1.19 1.49 1.55 1.14 1.50 1.57
Samidorphan 35.2 51.8 63.0 74.0 261 321 495 604
Ratioa 1.47 1.79 2.10 1.23 1.90 2.32

Abbreviations: AUCss, area under the plasma drug concentration‐time curve at steady state; Cmax,ss maximum plasma concentration at steady state; HI, hepatic impairment; OLZ/SAM, combination of olanzapine and samidorphan.

a

Relative to age‐matched controls with normal hepatic function.